The extent to which [14C] glutamate is converted into glutamine in brain greatly depends on its carbon source. Glutamine is highly labelled relative to glutamate with precursors such as bicarbonate, acetate, aspartate and leucine, but less labelled with glucose (reviewed by Berl & Clarke, 1969) . These observations are explainable by the presence in brain of at least two glutamate pools, with two distinct tricarboxylic acid cycles. Glutamine is formed mainly from the smaller of these pools Van den Berg, Mela & Waelsch, 1966; Van den Berg, Krzalic, Mela & Waelsch, 1969) . The enormous complexities of these metabolic pathways have encouraged the use of computer simulation methods to provide a quantitative picture of the entire system (Garfinkel, 1962 . Previous simulations based mainly on data from rats and cats (with bicarbonate, glutamate, aspartate and [15N]ammonia as precursors) led to the formulation of a model containing two tricarboxylic acid cycles .
Fairly detailed data for the time course of incorporation of 14C-labelled glucose and acetate into glutamate, glutamine and aspartate is now available for mice (Van den Berg et al. 1966 . We have performed a computer simulation of this data, primarily to find the simplest model that would explain this data as an aid in interpreting it. This approach differs from that in earlier studies , in which attempts were made * Present address: Study Group Inborn Errors and Brain, Dept. of Biological Psychiatry, Faculty ofMedicine, University of Groningen, Groningen, The Netherlands.
to explain all available literature data for the several precursors in different animals. It yields a simpler and less sophisticated model, but one based entirely on data from one source (avoiding problems in combining data from different sources). However, the compartmentations indicated by the two models are concordant.
METHODS
The model reported here was constructed using the chemical simulation language of Garfinkel (1968) . Reactions representing carbon atom transitions for all metabolites were written in a standard form: SSUCC*1 = SFUM*1, SSUCC*2 =SFUM*2, ... for all carbon atoms in the molecule. The asterisk indicates a labelled carbon atom and the number its position. The prefixes 'S' or 'L' distinguish between metabolites of small and large compartments. The model is defined by Tables 1 and 2 and summarized in Scheme 1. The reactions in Table 2 are translated into differential equations and solved for radioactivities as a function of time by the simulation program (Garfinkel, 1968 profiles and/or pulse labelling. The glucose input was finally shaped so as to correspond to the observed timecourse of glucose labelling in the brain, by using as input a curve constructed from the time derivative of the observed radioactivity (Dzubow & Garfinkel, 1970) . Acetate was assumed to be 100% labelled at zero time, i.e. 'pulse' labelling. AsUsmptions and 8implification8. The model consists of glycolysis and two tricarboxylic acid cycles. Glucose was a precursor of both cycles, acetate of only one. All the individual carbon atoms were traced through the model. The number of equations of the type shown in Table 2 required to represent all reactions among the tricarboxylic acid-cycle intermediates and glutamate pools in this way is greater than 400 (Dzubow & Garfinkel, 1970) . In order to permit economical calculation we substantially simplified this model, as follows.
Glycolysis was condensed to: GLUCOSE-+PYRUVATE, where PYRUVATE is the sum of pyruvate and lactate. The glycolytic intermediate pool in brain is small compared with the glucose flux (Lowry, Passonneau, Hasselberger & Schulz, 1964) , and the lactate dehydrogenase reaction appears far faster than the conversion of pyruvate into acetyl-CoA ( Van den Berg et al. 1969) .
The tricarboxylic acid cycle is represented by four reactions: the entrance of acetyl-CoA, decarboxylation of citrate and a-oxoglutarate, and the regeneration of oxaloacetate. In roughly computer language (Garfinkel, 1968) (Garfinkel, 1970) Lowry, 1966) , and about 1.51umol/g wet wt./min of acetyl CoA enters the cycle . As the first data point was 5min after precursor injection (Van den Berg et al. 1969 ) these simplifications will not seriously disturb the calculations. It should also be noted that the pool sizes of glutamate, aspartate and glutamine total about 20 jmol/g wet wt., more than 10-fold greater than the total cycle intermediates.
The glutamate pool in the compartment which metabolizes most of the glucose (the large compartment) was assumed to consist of two sub-pools (Garfinkel, 1970) ; this assumption was not made for the other compartment because its two sub-pools equilibrate rapidly . y-Aminobutyrate was assumed to be formed in the large compartment (C. J. Van den Berg, unpublished work), and degraded in the small compartment, as it has been shown that y-aminobutyrate gives rise to high relative specific radioactivities of glutamine in vivo and in vitro (Baxter, 1968; Nicklas, 1968; Balazs, Machiyama, Hammond, Julian & Richter, 1970) . The rate of net CO2 fixation equals the efflux of amino acids from the system, approximately 10% of the rate of acetyl-CoA utilization. About the same amount of the radioactivity in the brain was present in the trichloroacetic acid-insoluble fraction starting with ['4C]glucose (C. J. Van den Berg, unpublished work). Lipid formation was not considered. The data used here are from experiments with fed animals, which do differ from starved ones (Van den Berg et al. 1969) .
Model finally adopted. After considerable trial and error, we arrived at model parameters which matched the observed data reasonably closely (except for the 5min point with glucose). In this process, rate constants were manipulated more often than pool sizes, which should be regarded as less accurately fixed. In Tables 3 and 4 Table 2. A. Reactions and fluxes account for-nearly all the glutamate labelling) and different from that for the oxaloacetate-aspartate exchange. Most of the glutamate is present in the large compartment, and much of it must equilibrate rapidly with a-oxoglutarate. The massive incorporation of glucose radioactivity into glutamate also indicates rapid exchange between the two glutamate pools in the large compartment. However, the work of Patel, Balazs & Richter (1970) , who found the smaller of these pools 57% more highly labelled after 10 min., does argue for a slower exchange than that arrived at here.
5. Rate of glutamine and y-aminobutyrate movements between the two compartments. Numerical parameters which fitted the observed data were easily found following the assumptions (discussed below) of glutamine flow from the small to the large compartment and the reverse and equal flow of yaminobutyrate. A glutamine flow of 0.137,uLmol/g wet wt./min was found to be adequate and better than 0.1 and 0.160 respectively. This is about twice the value found by Dzubow & Garfinkel (1970) for the rat, but there is a general tendency for the flows reported here to be faster than they found, presumably due to species differences. The [2-14C]-acetate/[l-14C]acetate labelling ratio for glutamate increases so rapidly with time, because the contribution of glutamate from the large compartment is so large. The small compartment glutamate behaves like glutamine.
DISCUSSION
The essential features of the model described in this paper are the following. 1. There are two tricarboxylic acid cycles, which are the same two indicated directly by the labelling patterns starting from specifically "4C-labelled acetate (Van den Berg et al. 1969) . 2. These two tricarboxylic acid cycles are connected by glutamine and yaminobutyrate.
The presence of two tricarboxylic acid cycles in the brain is based on an analysis of the incorporation' of a large number of precursors into glutamate and glutamine (review, Berl & Clarke, 1969) and on previous simulation studies . There are two categories of glutamate and glutamine precursors: (1) Van den Berg et al. 1969; Berl & Frigyesi, 1969) ; y-aminobutyrate and propionate (via succinate) (Baxter, 1968; O'Neal, Koeppe & Williams, 1966) , primarily incorporated into glutamine. In addition the differences between glucose and acetate labelling pattems suggest the existence of two separate pathways from acetyl-CoA to a-oxoglutarate; this extends through to oxaloacetate because y-aminobutyrate and propionate behave like acetate. Also, the literature on enzyme distribution indicates the existence of at least two different mitochondrial populations, one rich in such enzymes as succinate dehydrogenase (Neidle, Van den Berg & Grynbaum, 1969; Salganicoff & DeRobertis, 1965) and glutaminase (Salganicoff & DeRobertis, 1965; Blokhuis, 1970) , and the other rich in acetyl-CoA synthetase (Neidle et al. 1969 ), y-aminobutyrate transaminase (Van Kempen, Van den Berg, Van der Helm & Veldstra, 1965) and glutamate dehydrogenase (Neidle et al. 1969) , which are necessary in the metabolism of such glutamine precursors as acetate, y -aminobutyrate and ammonia.
The y-aminobutyrate pathway has been considered to be a simple shunt of the tricarboxylic acid cycle, i.e., equimolar amounts of y-aminobutyrate are formed from glutamate and degraded to succinate; but it is questionable if the glutamate is associated with the same cycle as the succinate. The main arguments are: (a) the rapid labelling of y-aminobutyrate by glucose (Gaitonde, Dahl & Elliott, 1965; Minard & Mushahwar, 1966) ; (b) the slow labelling of y-aminobutyrate by glutamate, aspartate and leucine (Berl, Lajtha & Waelsch, 1961; Berl & Clarke, 1969) ; (c) One cycle is therefore continuously losing intermediates to the other. This may be balanced by CO2 fixation in one cycle, forming oxaloacetate from pyruvate, and the reverse reaction in the other cycle, or by a net counter-flow in the opposite direction to y-aminobutyrate flow, which may involve more than one substance (Garfinkel, 1970) .
It has been established that the specific radioactivity of glutamine in mouse brain injected with [1-_14C]acetate reaches a maximum before glutamate (Table 4) followed by a rapid decline in glutamine specific radioactivity. This may be due either to glutamine efflux from the brain (which has never been demonstrated as occurring to a sufficient extent), or to the conversion of glutamine (or some substance equilibrated with it) to glutamate, which may be in either compartment. The [2-14C] Such a flow from the small to the large compartment can be independently determined from the data of Berl et al. (1961) : the two compartments equilibrate (starting with labelling in the small one), but require more than an hour to do so in the rat. Analysis of their data indicates that aspartate also participates in this flow, although glutamine predominates (Garfinkel, 1970) .
A crucial assumption of this model is then that a compound (glutamine) moves from one brain compartment to another and that another compound (y-aminobutyrate) moves in the opposite direction.
Losses or gains in concentrations of tricarboxylic acid cycle intermediates could be compensated for by C02 fixation (or release) which is well established as occurring in brain (Berl, Takagaki, Clarke & Waelsch, 1962; Salganicoff & Koeppe, 1968) , although difficult to assign to specific compartments. The apparent preferential incorporation of 14C02 in glutamine (Berl et al. 1962) might be because the "4CO2 is diluted more strongly in the large than in the small compartment. The almost equal incorporation of radioactivity from [3,4-14C] glucose in glutamate and glutamine in mouse brain (C. J. Van den Berg, unpublished work) argues in favour of this latter possibility. There is no doubt that more experimental data is required to settle these points, and that it is presently impossible to discard the possibility that CO2 fixation and release are involved in balancing the concentrations of tricarboxylic acid-cycle intermediates in the brain.
It should be kept in mind that this study has been devoted to one particular facet of the complex metabolism of a complex organ, and that the results may therefore suggest that the situation is much simpler than we know it actually is. This work was supported by Grants GM-AM 16501 and RR-15 and by a Research Career Development Award (to D.G.) from the National Institutes of Health.
